Gevokizumab, an interleukin-1β (IL-1β) monoclonal antibody (mAb), in metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer (mGEC) and metastatic renal cell carcinoma (mRCC): “first-in-cancer” phase Ib study

E. Van Cutsem; K. Shitara; W. Deng; A. Vaury; L. Tseng; X. Wang; J. Millholland; M. Shilkrut; B. Mookerjee; E. Jonasch

doi:10.1093/annonc/mdz155.283

Gevokizumab, an interleukin-1β (IL-1β) monoclonal antibody (mAb), in metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer (mGEC) and metastatic renal cell carcinoma (mRCC): “first-in-cancer” phase Ib study

E. Van Cutsem, K. Shitara, W. Deng, A. Vaury, L. Tseng, X. Wang, J. Millholland, M. Shilkrut, B. Mookerjee, E. Jonasch

Genitourinary Medical Oncology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	iv77-iv78
Journal	Annals of Oncology
Volume	30
DOIs	https://doi.org/10.1093/annonc/mdz155.283
State	Published - Jul 2019

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdz155.283

Cite this

Van Cutsem, E., Shitara, K., Deng, W., Vaury, A., Tseng, L., Wang, X., Millholland, J., Shilkrut, M., Mookerjee, B., & Jonasch, E. (2019). Gevokizumab, an interleukin-1β (IL-1β) monoclonal antibody (mAb), in metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer (mGEC) and metastatic renal cell carcinoma (mRCC): “first-in-cancer” phase Ib study. Annals of Oncology, 30, iv77-iv78. https://doi.org/10.1093/annonc/mdz155.283

Gevokizumab, an interleukin-1β (IL-1β) monoclonal antibody (mAb), in metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer (mGEC) and metastatic renal cell carcinoma (mRCC): “first-in-cancer” phase Ib study. / Van Cutsem, E.; Shitara, K.; Deng, W. et al.
In: Annals of Oncology, Vol. 30, 07.2019, p. iv77-iv78.

Research output: Contribution to journal › Article › peer-review

Van Cutsem, E, Shitara, K, Deng, W, Vaury, A, Tseng, L, Wang, X, Millholland, J, Shilkrut, M, Mookerjee, B & Jonasch, E 2019, 'Gevokizumab, an interleukin-1β (IL-1β) monoclonal antibody (mAb), in metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer (mGEC) and metastatic renal cell carcinoma (mRCC): “first-in-cancer” phase Ib study', Annals of Oncology, vol. 30, pp. iv77-iv78. https://doi.org/10.1093/annonc/mdz155.283

Van Cutsem E, Shitara K, Deng W, Vaury A, Tseng L, Wang X et al. Gevokizumab, an interleukin-1β (IL-1β) monoclonal antibody (mAb), in metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer (mGEC) and metastatic renal cell carcinoma (mRCC): “first-in-cancer” phase Ib study. Annals of Oncology. 2019 Jul;30:iv77-iv78. doi: 10.1093/annonc/mdz155.283

@article{7a66152d87494e5aa3803270c77c1d22,

title = "Gevokizumab, an interleukin-1β (IL-1β) monoclonal antibody (mAb), in metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer (mGEC) and metastatic renal cell carcinoma (mRCC): “first-in-cancer” phase Ib study",

author = "{Van Cutsem}, E. and K. Shitara and W. Deng and A. Vaury and L. Tseng and X. Wang and J. Millholland and M. Shilkrut and B. Mookerjee and E. Jonasch",

year = "2019",

month = jul,

doi = "10.1093/annonc/mdz155.283",

language = "English (US)",

volume = "30",

pages = "iv77--iv78",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Gevokizumab, an interleukin-1β (IL-1β) monoclonal antibody (mAb), in metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer (mGEC) and metastatic renal cell carcinoma (mRCC)

T2 - “first-in-cancer” phase Ib study

AU - Van Cutsem, E.

AU - Shitara, K.

AU - Deng, W.

AU - Vaury, A.

AU - Tseng, L.

AU - Wang, X.

AU - Millholland, J.

AU - Shilkrut, M.

AU - Mookerjee, B.

AU - Jonasch, E.

PY - 2019/7

Y1 - 2019/7

UR - http://www.scopus.com/inward/record.url?scp=85079796116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85079796116&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdz155.283

DO - 10.1093/annonc/mdz155.283

M3 - Article

C2 - 32085292

SN - 0923-7534

VL - 30

SP - iv77-iv78

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Gevokizumab, an interleukin-1β (IL-1β) monoclonal antibody (mAb), in metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer (mGEC) and metastatic renal cell carcinoma (mRCC): “first-in-cancer” phase Ib study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this